The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment
Open accessAbstract
Skeletal complications caused by osteoporosis or bone metastases are associated with considerable pain, increased mortality, and reduced quality of life. Furthermore, such events place a burden on health care resources. Agents that prevent bone resorption, such as bisphosphonates or denosumab, can reduce the risk of skeletal-related events and are widely used in patients with osteoporosis or bone metastases of cancer. Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but potentially serious, adverse event associated with high cumulative doses of bisphosphonates or denosumab. However, MRONJ can be treated, and the likelihood of the development of this condition can be reduced through prophylactic dental care and the maintenance of good oral hygiene. Dentists, as part of a multiprofessional team, have a critical role in preventing MRONJ. This review describes the incidence and pathophysiology of MRONJ and provides guidance for dental practitioners with regard to the screening, prophylactic treatment, diagnosis, and management of patients with this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Oral and maxillofacial pathology
(1996) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(96)90514-5 · Cited by 2,967
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.031 · Cited by 2,905
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Coleman, R. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0931 · Cited by 2,488
An overview and management of osteoporosis
Sözen, T., Özışık, L., & Çalık Başaran, N. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2016.048 · Cited by 2,262
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Bisphosphonates: Mechanism of action and role in clinical practice
Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Skeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
Haentjens, P., Magaziner, J., Colón-Emeric, C. S., Vanderschueren, D., Milisen, K., Velkeniers, B., & Boonen, S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00008 · Cited by 1,398
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,353
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30138-9 · Cited by 996
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A., Mackey, J., Apffelstaedt, J., Hussein, M. A., Coleman, R. E., Reitsma, D. J., et al. (2003) · Cancer · doi:10.1002/cncr.11701 · Cited by 873
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Macedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.321 · Cited by 775
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
Thomas, D., Henshaw, R., Skubitz, K., Chawla, S., Staddon, A., Blay, J.-Y., Roudier, M., Smith, J., Ye, Z., Sohn, W., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70010-3 · Cited by 716
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Adler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
Bone, H. G., Bolognese, M. A., Yuen, C. K., Kendler, D. L., Miller, P. D., Yang, Y.-C., Grazette, L., San Martin, J., & Gallagher, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1502 · Cited by 623
Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.002 · Cited by 588
Miller, P. D., Bolognese, M. A., Lewiecki, E. M., McClung, M. R., Ding, B., Austin, M., Liu, Y., & San Martin, J. (2008) · Bone · doi:10.1016/j.bone.2008.04.007 · Cited by 578
Bone health in cancer patients: ESMO Clinical Practice Guidelines
Coleman, R., Body, J. J., Aapro, M., Hadji, P., & Herrstedt, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu103 · Cited by 564
Gnant, M., Pfeiler, G., Dubsky, P. C., Hubalek, M., Greil, R., Jakesz, R., Wette, V., Balic, M., Haslbauer, F., Melbinger, E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60995-3 · Cited by 559
Kohno, N., Aogi, K., Minami, H., Nakamura, S., Asaga, T., Iino, Y., Watanabe, T., Goessl, C., Ohashi, Y., & Takashima, S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.116 · Cited by 546
Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., Hutchinson, M., Lathon, P. V., Sanchez, G., Silver, P., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.050 · Cited by 493
Major osteoporotic fragility fractures: Risk factor updates and societal impact
Pisani, P., Renna, M. D., Conversano, F., Casciaro, E., Di Paola, M., Quarta, E., Muratore, M., & Casciaro, S. (2016) · World Journal of Orthopedics · doi:10.5312/wjo.v7.i3.171 · Cited by 491
Raje, N., Terpos, E., Willenbacher, W., Shimizu, K., García-Sanz, R., Durie, B., Legieć, W., Krejčí, M., Laribi, K., Zhu, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30072-x · Cited by 449
Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Branstetter, D. G., Nelson, S. D., Manivel, J. C., Blay, J.-Y., Chawla, S., Thomas, D. M., Jun, S., & Jacobs, I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0578 · Cited by 426
Hellstein, J. W., Adler, R. A., Edwards, B., Jacobsen, P. L., Kalmar, J. R., Koka, S., Migliorati, C. A., & Ristic, H. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0108 · Cited by 363
Fliefel, R., Tröltzsch, M., Kühnisch, J., Ehrenfeld, M., & Otto, S. (2015) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2015.01.026 · Cited by 363
Hypercalcemia of malignancy: An update on pathogenesis and management
Mirrakhimov, A. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.170600 · Cited by 290
on behalf of the DAPS Investigators, Freemantle, N., Satram-Hoang, S., Tang, E.-T., Kaur, P., Macarios, D., Siddhanti, S., Borenstein, J., & Kendler, D. L. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1780-1 · Cited by 288
Osteonecrosis of the Jaw in a Patient on Denosumab
Aghaloo, T. L., Felsenfeld, A. L., & Tetradis, S. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.10.010 · Cited by 275
Khan, A. A., Morrison, A., Kendler, D. L., Rizzoli, R., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., et al. (2017) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.09.005 · Cited by 264
Macedo, F. (2017) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2017.04.555637 · Cited by 257
Miller, P. D., Pannacciulli, N., Brown, J. P., Czerwinski, E., Nedergaard, B. S., Bolognese, M. A., Malouf, J., Bone, H. G., Reginster, J.-Y., Singer, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1801 · Cited by 243
Osteonecrosis of the jaws induced by anti-RANK ligand therapy
Taylor, K. H., Middlefell, L. S., & Mizen, K. D. (2010) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2009.08.030 · Cited by 228
Dhesy-Thind, S., Fletcher, G. G., Blanchette, P. S., Clemons, M. J., Dillmon, M. S., Frank, E. S., Gandhi, S., Gupta, R., Mates, M., Moy, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.7257 · Cited by 222
Rupel, K., Ottaviani, G., Gobbo, M., Contardo, L., Tirelli, G., Vescovi, P., Di Lenarda, R., & Biasotto, M. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.08.016 · Cited by 214
Denosumab for Treatment of Hypercalcemia of Malignancy
Hu, M. I., Glezerman, I. G., Leboulleux, S., Insogna, K., Gucalp, R., Misiorowski, W., Yu, B., Zorsky, P., Tosi, D., Bessudo, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1001 · Cited by 203
Otto, S., Tröltzsch, M., Jambrovic, V., Panya, S., Probst, F., Ristow, O., Ehrenfeld, M., & Pautke, C. (2015) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2015.03.039 · Cited by 190
Quality of Life Implications of Bisphosphonate-Associated Osteonecrosis of the Jaw
Miksad, R. A., Lai, K.-C., Dodson, T. B., Woo, S.-B., Treister, N. S., Akinyemi, O., Bihrle, M., Maytal, G., August, M., Gazelle, G. S., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0183 · Cited by 179
Wilde, F., Heufelder, M., Winter, K., Hendricks, J., Frerich, B., Schramm, A., & Hemprich, A. (2011) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2010.04.015 · Cited by 175
Oral Health Risk Factors for Bisphosphonate-Associated Jaw Osteonecrosis
Tsao, C., Darby, I. B., Ebeling, P. R., Walsh, K. A., O’brien-simpson, N. M., Reynolds, E. C., & Borromeo, G. L. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.02.016 · Cited by 166
Hypercalcemia of malignancy and new treatment options
Glezerman, I. G., & Sternlicht, H. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s83681 · Cited by 159
Ripamonti, C. I., Cislaghi, E., Mariani, L., & Maniezzo, M. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.01.002 · Cited by 156
Self-citationHasegawa, T., Kawakita, A., Ueda, N., Funahara, R., Tachibana, A., Kobayashi, M., Kondou, E., Takeda, D., Kojima, Y., Sato, S., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4063-7 · Cited by 156
Denosumab for the treatment of osteoporosis
Zaheer, S., LeBoff, M. S., & Lewiecki, E. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1000860 · Cited by 142
Bedogni, A., Saia, G., Bettini, G., Tronchet, A., Totola, A., Bedogni, G., Ferronato, G., Nocini, P. F., & Blandamura, S. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.02.024 · Cited by 137
Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015
Khan, A. A., Morrison, A. D., Cheung, A. M., Hashem, W., & Compston, J. E. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3335-3 · Cited by 133
Gaudin, E., Seidel, L., Baćević, M., Rompen, E., & Lambert, F. (2015) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12455 · Cited by 133
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications
D’Oronzo, S., Stucci, L. S., Tucci, M., & Silvestris, F. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.09.003 · Cited by 126
Fedele, S., Bedogni, G., Scoletta, M., Favia, G., Colella, G., Agrillo, A., Bettini, G., Fede, O. D., Oteri, G., Fusco, V., et al. (2014) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2014.09.001 · Cited by 122
Renal safety in patients treated with bisphosphonates for osteoporosis: A review
Miller, P. D., Jamal, S. A., Evenepoel, P., Eastell, R., & Boonen, S. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2058 · Cited by 117
Bedogni, A., Fedele, S., Bedogni, G., et al. (2014) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2014.04.009 · Cited by 117
von Moos, R., Body, J.-J., Egerdie, B., Stopeck, A., Brown, J. E., Fallowfield, L. J., Patrick, D. L., Cleeland, C. S., Damyanov, D., Palazzo, F. G., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2908-1 · Cited by 114
Sivolella, S., Lumachi, F., Stellini, E., & Favero, L. (2013) · PubMed · Cited by 111
Giant cell tumour of bone: new treatments in development
Pousa, A. L., Martín‐Broto, J., Garrido, T., & Vázquez, J. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1268-5 · Cited by 110
Efficacy, effectiveness and side effects of medications used to prevent fractures
Reid, I. R. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12339 · Cited by 105
Hopkins, R. B., Goeree, R. A., Pullenayegum, E., Adachi, J. D., Παπαϊωάννου, Α., Xie, F., & Thabane, L. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-209 · Cited by 103
Pimolbutr, K., Porter, S. R., & Fedele, S. (2018) · BioMed Research International · doi:10.1155/2018/8071579 · Cited by 101
The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
Byun, J.-H., Jang, S., Lee, S., Park, S., Yoon, H. K., Yoon, B., & Ha, Y. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.37 · Cited by 98
Hadji, P., Παπαϊωάννου, Ν., Gielen, E., Tepie, M. F., Zhang, E., Frieling, I., Geusens, P., Makras, P., Resch, H., Möller, G., et al. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3164-4 · Cited by 93
Patel, S. K., Choyee, S. K., Uyanne, J., Nguyen, A., Lee, P., Sedghizadeh, P. P., Kumar, S., Lytle, J. J., Shi, S., & Le, A. (2012) · Oral Diseases · doi:10.1111/j.1601-0825.2012.01911.x · Cited by 91
Lombard, T., Neirinckx, V., Rogister, B., Gilon, Y., & Wislet‐Gendebien, S. (2016) · Stem Cells International · doi:10.1155/2016/8768162 · Cited by 81
Neto, A. S., Tobias‐Machado, M., Esteves, M. A., Senra, M. D., Wroclawski, M. L., Fonseca, F. L. A., dos Reis, R. B., Pompeo, A. C. L., & del Giglio, A. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.4 · Cited by 79
Denosumab in Osteoporosis and Oncology
Burkiewicz, J. S., Scarpace, S. L., & Bruce, S. P. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m102 · Cited by 77
Pittman, K. B., Antill, Y. C., Goldrick, A., Goh, J. C. H., & Boer, R. H. D. (2016) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12517 · Cited by 77
Bacterial diversity in medication-related osteonecrosis of the jaw
Hallmer, F., Bjørnland, T., Andersson, G., Becktor, J. P., Kristoffersen, A. K., & Enersen, M. (2016) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2016.11.011 · Cited by 75
Martín‐Broto, J., Cleeland, C. S., Glare, P. A., Engellau, J., Skubitz, K. M., Blum, R. H., Ganjoo, K. N., Staddon, A. P., Dominkus, M., Feng, A., et al. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.910313 · Cited by 69
Troeltzsch, M., Cagna, D. R., Stähler, P., Probst, F., Kaeppler, G., Troeltzsch, M., Ehrenfeld, M., & Otto, S. (2016) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2016.09.018 · Cited by 67
Chen, F., & Pu, F. (2016) · Oncology Research and Treatment · doi:10.1159/000447372 · Cited by 64
Fred Saad, C., Ivanescu, C., Phung, D., Loriot, Y., Abhyankar, S. S., Beer, T. M., TOMBAL, B. F., & Holmström, S. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2016.62 · Cited by 64
Schiødt, M., Vadhan‐Raj, S., Chambers, M. S., Nicolatou‐Galitis, O., Politis, C., Coropciuc, R., Fedele, S., Jandial, D., Zhang, J., Ma, H., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-4003-2 · Cited by 63
Self-citationSafety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
Carbonare, L. D., Zanatta, M., Gasparetto, A., & Valenti, M. T. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s6285 · Cited by 57
Treatment of Paget’s Disease of Bone with Denosumab: Case Report and Literature Review
Reid, I. R., Sharma, S., Kalluru, R., & Eagleton, C. L. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0150-6 · Cited by 57
Risk of Serious Atrial Fibrillation and Stroke With Use of Bisphosphonates
Sharma, A., Chatterjee, S., Arbab‐Zadeh, A., Goyal, S., Lichstein, E., Ghosh, J., & Aikat, S. (2013) · CHEST Journal · doi:10.1378/chest.13-0675 · Cited by 54
Osteonecrosis of the jaw a new complication related to Ipilimumab
Owosho, A. A., Scordo, M., Yom, S. K., Randazzo, J. D., Chapman, P. B., Huryn, J. M., & Estilo, C. L. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.08.014 · Cited by 51
Hoefeler, H., Durán, I., Hechmati, G., Garzón-Rodríguez, C., Lüftner, D., Ashcroft, J., Bahl, A., Atchison, C., Wei, R., Thomas, E., et al. (2014) · Journal of bone oncology · doi:10.1016/j.jbo.2014.04.001 · Cited by 50
Estimating the long-term functional burden of osteoporosis-related fractures
Fischer, S. H., Kapinos, K. A., Mulcahy, A. W., Pinto, L. A., Hayden, O., & Barron, R. L. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4110-4 · Cited by 50
McKay, R., Haider, B., Duh, M. S., Valderrama, A., Nakabayashi, M., Fiorillo, M., Ristovska, L., Wen, L., & Kantoff, P. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2017.4 · Cited by 49
Hinson, A. M., Siegel, E. R., & Stack, B. C. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.07.012 · Cited by 47
Then, C., Hörauf, N., Otto, S., Pautke, C., von Tresckow, E., Röhnisch, T., Baumann, P., Schmidmaier, R., Bumeder, I., & Oduncu, F. S. (2012) · Onkologie · doi:10.1159/000343950 · Cited by 47
New cancer therapies and jaw necrosis
Patel, V., Kelleher, M., Sproat, C., Kwok, J., & McGurk, M. (2015) · BDJ · doi:10.1038/sj.bdj.2015.680 · Cited by 47
A rare case of osteonecrosis of the jaw related to imatinib
Viviano, M., Rossi, M., & Cocca, S. (2017) · 대한구강악안면외과학회지 · doi:10.5125/jkaoms.2017.43.2.120 · Cited by 45
Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom
Hechmati, G., Hauber, B., Arellano, J., Mohamed, A. F., Qian, Y., Gatta, F., Haynes, I., Bahl, A., von Moos, R., & Body, J. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2309-x · Cited by 41
Drug-induced osteonecrosis of the jaw: the state of the art
Fassio, A., Bertoldo, F., Idolazzi, L., Viapiana, O., Rossini, M., & Gatti, D. (2017) · Reumatismo · doi:10.4081/reumatismo.2017.983 · Cited by 39
Mergoni, G., Vescovi, P., Sala, R., Merigo, E., Passerini, P., Maestri, R., Corradi, D., Govoni, P., Nammour, S., & Bianchi, M. G. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2847-x · Cited by 37
Prevention and treatment of bone fragility in cancer patient
Ottanelli, S. (2015) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2015.12.2.116 · Cited by 35
Ponzetti, A., Pinta, F., Spadi, R., Mecca, C., Fanchini, L., Zanini, M., Ciuffreda, L., & Racca, P. (2015) · Tumori Journal · doi:10.5301/tj.5000405 · Cited by 32
Hanley, D. A., McClung, M. R., Davison, K. S., Dian, L., Harris, S. T., Miller, P. D., Lewiecki, E. M., & Kendler, D. L. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.03.002 · Cited by 31
Body, J., Pereira, J., Sleeboom, H. P., Maniadakis, N., Terpos, E., Acklin, Y. P., Fínek, J., Gunther, O., Hechmati, G., Mossman, T., et al. (2015) · The European Journal of Health Economics · doi:10.1007/s10198-015-0716-7 · Cited by 30
Current perspectives on bisphosphonate treatment in Paget’s disease of bone
Wat, W. Z. M. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s58367 · Cited by 30
Persistence with denosumab and zoledronic acid among older women: a population-based cohort study
Tremblay, É., Perreault, S., & Dorais, M. (2016) · Archives of Osteoporosis · doi:10.1007/s11657-016-0282-3 · Cited by 27
Cost and Consequences of Noncompliance to Oral Bisphosphonate Treatment
Eisenberg, D. F., Placzek, H., Gu, T., Krishna, A., & Tulsi, B. B. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.1.56 · Cited by 26
Migliario, M., Mergoni, G., Vescovi, P., Martino, I. D., Alessio, M., Benzi, L., Renò, F., & Fusco, V. (2017) · Dentistry Journal · doi:10.3390/dj5010013 · Cited by 20
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors
Qian, Y., Arellano, J., Hauber, B., Mohamed, A. F., González, J. M., Hechmati, G., Gatta, F., Harrelson, S. S., & Campbell‐Baird, C. (2016) · Patient · doi:10.1007/s40271-015-0158-4 · Cited by 13
Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
Egbert, R. C., Folsom, R., Bell, J., & Rajani, R. (2017) · Case Reports in Orthopedics · doi:10.1155/2017/2302597 · Cited by 12
Matsuo, A., Hamada, H., Kaise, H., Chikazu, D., Yamada, K., & Kohno, N. (2014) · Acta Odontologica Scandinavica · doi:10.3109/00016357.2014.887772 · Cited by 10
de Boissieu, P., Kanagaratnam, L., Mahmoudi, R., Morel, A. D., Dramé, M., & Trenque, T. C. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2210-x · Cited by 10
Taking the lead – Sharing best practice in intravenous bisphosphonate use in urological cancers
Jensen, B. T., Dielenseger, P., Drudge‐Coates, L., Flynn, K., Hieronymi, S., van Muilekom, H. A. M., Pieters, R., & Voss, L. B. (2011) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2011.02.006 · Cited by 7
Self-citation
Cited by
Coleman, R. E., Croucher, P. I., Padhani, A. R., Clézardin, P., Chow, E., Fallon, M., Guise, T., Colangeli, S., Capanna, R., & Costa, L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00216-3 · Cited by 570
Metadata
- Authors
- Nicolatou-Galitis, O., Schiødt, M., Mendes, R. A., Ripamonti, C., Hope, S., Drudge-Coates, L., Niepel, D., & Van den Wyngaert, T.
- Venue
- Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 127
- Issue
- 2
- Pages
- 117-135
- ISSN
- 2212-4403 (ISSN-L)
- OpenAlex
- W2896174631
- Cited by
- 361
- References
- 108
- FWCI
- 10.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.